GARS1 and peripheral neuropathy: Indeed, therapeutic tRNA overexpression can rescue peripheral neuropathy in animal and cellular models of Charcot–Marie–Tooth disease caused by mutations in glycyl-tRNA synthetase, demonstrating the potential of tRNA therapeutics [66].